XORTX Therapeutics Inc. Gains 43.8%
Wed, Mar 23, 2022 at 05:30 PM
XORTX Therapeutics Inc. (XRTX:NASDAQ) shot up at $1.74, a gain of 43.8%. The stock got featured on our News Catalysts scanner on Wed, Mar 23, 2022 at 08:15 AM in the 'BIOTECH' category. From Wed, Mar 09, 2022, the stock recorded 44.44% Up Days and 30.00% Green Days
The stock spiked on Thu, Nov 04, 2021 at $5.89 with a volume of 28M+.
About XORTX Therapeutics Inc. (XRTX:NASDAQ)
XORTX Therapeutics Inc is focused on developing drug therapies for orphan disease like polycystic kidney disease, and treatment of health consequences caused by chronic high serum uric acid which...
Top 10 Gainers:
- XORTX Therapeutics Inc. (XRTX:NASDAQ), 43.8%
- Imperial Petroleum Inc. (IMPP:NASDAQ), 37.25%
- Miromatrix Medical Inc. (MIRO:NASDAQ), 35.92%
- Four Seasons Education (Cayman) Inc. (FEDU:NYSE), 35.4%
- Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ), 29.98%
- 4D pharma plc (LBPS:NASDAQ), 28.48%
- Elite Education Group International Ltd. (EEIQ:NASDAQ), 27.36%
- Zentek Ltd. (ZTEK:NASDAQ), 25.93%
- Enveric Biosciences Inc. (ENVB:NASDAQ), 24.37%
- Femasys Inc. (FEMY:NASDAQ), 24.34%